Findings drawn from published studies — what is moving a market, who supplies it, and where the growth sits. Every article links to the research it came from.
4 articles
CDI sizes the antimicrobial susceptibility testing market at USD 9.68 billion by 2034, growing 8.5% a year, with a nine-axis segmentation that shows where the demand actually sits.
Read the article →CDI's swine vaccines market report puts the market at USD 3.411 billion by 2034 at a 7% CAGR, with a ten-axis segmentation still awaiting disclosed regional and segment shares.
The hepatitis E vaccines market reaches USD 247.5 million by 2034 at a 20.62% CAGR, built on a ten-axis segmentation still splitting revenue across five vaccine platforms and five regulatory stages.
The telemedicine market is forecast to grow from USD 140 billion in 2025 to USD 572.35 billion by 2034, with growth concentrated in one component line and one region.